YouScript: A Unique, State of the Art, Healthcare Solution
Hear what Barry Bittman, MD has to say about YouScript. A well-respected member of the medical community, Dr. Bittman is a neurologist, author, international speaker, researcher and inventor. As CEO of the Institute for Innovative Healthcare, Dr. Bittman developed a new paradigm for comprehensive integrative strategies − engaging patients and communities in the active pursuit of health and well-being. Through extensive work in population health management, and as former Chief Population Health Officer, Bittman introduced numerous innovative risk stratification and evidence-based continuous care inpatient and outpatient protocols designed to achieve Triple Aim outcomes. We are excited to add his voice to the conversation about the importance and value of the work we are doing at YouScript.
“As a physician with four decades of extensive experience in domains that include private practice, leadership, hospital/system administration, innovation and consulting coupled with two peer-reviewed genomics research publications, I am personally convinced that there has never been a more favorable time in the history of healthcare evolution to fully integrate YouScript into system-wide workflows that are essential for ensuring Triple Aim outcomes.
Staggering double digit pharmacologic inflation is presently outstripping all available healthcare resources. The need for a rational cost-effective strategy that optimizes medication prescribing by specifically tailoring the drug regimen to the individual must not be underestimated. The potential for utilizing YouScript either at the practice level or through centralized population health integration holds great promise for optimizing appropriate prescribing, thereby eliminating ineffective drug regimens and improving both patient safety and outcomes.
While broad applicability certainly exists in the healthcare arena, this unique software approach in combination with advanced risk stratification is particularly applicable to the top 10% of patients who utilize more than 63% of all healthcare resources. From a practical perspective, the uniqueness of the YouScript approach is characterized by the option, rather than the requirement to proceed with genomic laboratory testing. In terms of cost containment, the opportunity to efficiently integrate YouScript into the electronic health record enables “top of the mind” thinking and practice transformation through high level decision support. Ultimately YouScript facilitates an unprecedented level of appropriate prescribing and pharmacological efficacy that leads to substantial improvements in both patient outcomes and care experiences with concomitant reductions of unnecessary spending.
Through its advanced state-of-the-art knowledge base coupled with a novel user-friendly clinical workflow interface, YouScript is destined to serve as an integral staple element of affordable effective healthcare.”
- Barry Bittman, MD
CEO, Institute for Innovative Healthcare
CEO, Yamaha Music & Wellness Institute
Dr. Bittman also serves as a Senior Fellow in the Estes Park Institute where he focuses on population health management, innovation, care coordination across the continuum, optimizing the patient experience and enabling physicians to assume executive leadership roles in healthcare. Furthermore, he developed the first of its kind interdisciplinary Community Health Coach curriculum and is CEO of the Yamaha Music & Wellness Institute, a non-profit organization that is actively engaged in education and research.
His work has been featured on CNN Headline News and in numerous leading publications throughout the world, including USA Today, Business Week, Time, Prevention, Discover, O (Oprah Magazine), the New York Times, the San Francisco Chronicle, the Washington Post, Scientific American, Men's Fitness and others.
Take a Risk Assessment
Simply enter the medications you’re currently on or plan to take. Click “Get Results” to see if your regimen puts you at risk for an adverse drug reaction.
YOUR GENELEX RISK ASSESSMENT RESULTS: